A practical clinical approach to the diagnosis and management of morphea (localized scleroderma).

Circumscribed Morphea Successfully Treated With Excimer Laser: Analysis of Histopathological Changes.

Human MAGI1 expression in endothelial cells protects from the development of localized and systemic scleroderma in mice.

Case of generalized morphea complicated with systemic sclerosis.

Injectable platelet-rich fibrin as a valid therapeutic option for inactive linear morphea (en coup de saber): report of cases.

Generalized Morphea Successfully Treated With Tripterygium Glycosides and Hydroxychloroquine: A Case Report and a Systematic Review.

Successful tocilizumab-based combination therapy for a case of rapidly progressive adult deep morphea with multiple antiphospholipid antibodies: a case report and literature review.

Replay: Comparative Study of Adipose-Derived Stem Cells from Localized Scleroderma Patients and Healthy Donors in Treating Skin Fibrosis.

Hyaluronic acid fillers in systemic sclerosis and localized scleroderma: A systematic review.

Ustekinumab-associated morphoea: systematic review of the literature and a real-world case.

Atypical Presentation of Morphoea in an Elderly Male: Diagnostic Challenges in the Absence of Autoantibodies and Malignancy.

Treatment of juvenile localized scleroderma with upadacitinib: A case series.

Methotrexate and Mycophenolate Mofetil and Clinical Response in Juvenile Localized Scleroderma.

Association of MMP9 and NOS3 Polymorphisms with Distinct Clinical Forms of Juvenile Scleroderma and Characteristics of Humoral Immunity.

JAK inhibitors for the treatment of juvenile localized scleroderma: a case report and literature review.

Botulinum neurotoxin type A1 alleviates bleomycin-induced skin fibrosis by inhibiting phosphatidylinositol 3-kinase-protein kinase B (PI3K-Akt) pathway and associated cell cycle and proliferation.

Tofacitinib treatment in a girl with localized scleroderma of the head and face: a case-based review.

Skin Cancer Arising in Morphea: A Systematic Review.

Disease Course and Risk of Relapse in Juvenile Localized Scleroderma: A Single-Center Retrospective Study.

Combination of Oral Hydroxychloroquine and Topical Pimecrolimus 1% for Linear Morphea in Breastfeeding: A Rare Case with Favorable Outcome.

Parry-Romberg Syndrome Associated With En Coup De Sabre: A Clinical Case Report.

Single-Cell Profiling Reveals Divergent Mechanisms of Fibrosis in Localized Scleroderma and Systemic Sclerosis.

Phosphodiesterase-4 inhibition in localized scleroderma: A case series of topical roflumilast.

Successful Treatment of Refractory Severe Localized Scleroderma With Anifrolumab.

Evaluation of localized scleroderma by line-field confocal optical coherence tomography.

Parry-Romberg Syndrome With Localized Scleroderma: A Report of Two Pediatric Cases From Oman.

[En coup de sabre linear scleroderma with central nervous system involvement in a pediatric patient].

Janus Kinase Inhibitors for the Treatment of Pediatric Morphea: A Systematic Review.

Temporal dynamics of ADSC therapy in skin fibrosis: unraveling the roles of ROS/NF-κB/TSG-6 signaling axis.

Remote Skin and Blood Sampling for Translational Connective Tissue Disorder Research: A Proof-of-Concept Pilot Study.

Barriers to Surgical Care in Craniofacial Scleroderma (Parry-Romberg Syndrome).

Localized scleroderma and related comorbidities: a single-centre cohort study.

Pansclerotic Morphea, Refractory to Multiple Systemic Therapies, Successfully Treated with UVA-1 Phototherapy.

Are systemic sclerosis and localized scleroderma (morphea) part of a common disease spectrum? A systematic review on their coexistence.

Pediatric Localized Scleroderma With Favorable Response to 308-nm Excimer Light Therapy.

Sclerosing diseases of the skin.

Revealing Microvascular Involvement in Pediatric Localized Scleroderma Through Nailfold Capillaroscopy.

Injectable Immune-Regulating Mesenchymal Stem Cells Hydrogel for Localized Scleroderma Treatment.

Sclerotic GVHD and scleroderma share dysregulated gene expression that is ameliorated by EREG therapeutic antibody.

Adipose-derived mesenchymal stem cells and their derivatives in inflammatory skin diseases: a systematic review.

Reviewing the Developing Significance of the Serine Protease PRSS23.

Recombinant Human Annexin A5 Ameliorates Localized Scleroderma by Inhibiting the Activation of Fibroblasts and Macrophages.

The Therapeutic Effects of Semaglutide in Congenital Linear Scleroderma.

Pirfenidone in Skin Fibrosis and Scarring: From Bench Insights to Clinical Data.

Plastic Surgery Interventions for Localized Scleroderma Deformities: an Evidence Synthesis.

Comparative Efficacy and Safety of Treatments for Morphea: A Systematic Review.

Autoimmune inner ear disease and localized scleroderma in childhood: A case report.

High-content Image-based Drug Testing of Patients' Primary Fibroblasts Reveals Potential New Treatment Options for Localized Scleroderma.

Nodular morphea on the breast of a pregnant woman-case report and literature review.

Asymptomatic Anterior Uveitis without Systemic Activity in en Coup de Sabre Scleroderma: A Case Report.

Janus kinase inhibitors in localized scleroderma: a systematic literature review.

Single-cell sequencing combined with spatial transcriptomics reveals the characteristics of follicle-targeted inflammation patterns in primary cicatricial alopecia.

Validation of CXCL9 as a biomarker of morphoea disease state and severity through longitudinal analysis.

Scleroderma Overlapping With Sjögren's Syndrome: A Case Report of a Renal Emergency.

Localized Morphea in a Pediatric Patient Successfully Treated With Topical Ruxolitinib.

The role of selected cytokines from the interleukin 1 family in the pathophysiology of morphea.

Pseudo oculomotor palsy associated with Parry-Romberg syndrome.

Is adiponectin involved in morphea pathogenesis? - first observational study.

[A case of autoinflammatory disease with STAT4 variant and localized scleroderma].

Juvenile localized scleroderma: a large retrospective cohort study from a tertiary care center.

Localized scleroderma: multiparametric MRI with diffusion-weighted imaging and gadolinium-based perfusion imaging for assessing disease activity.

Devastating neurologic consequences of localized scleroderma en coup de sabre of the scalp-2 case studies.

New Challenging Systemic Therapies for Juvenile Scleroderma: A Comprehensive Review.

Effect of UV-A1 Phototherapy Treatment on Scleroderma: A Systematic Review.

[Disseminated atrophoderma of Pasini and Pierini with blaschkoid appearance].

Successful treatment of localized scleroderma using brodalumab: A case report.

Use of the oral Janus kinase inhibitor tofacitinib in the treatment of morphea: A retrospective study.

Histopathological and molecular analysis in dermis and epidermis of patients with systemic and localized scleroderma.

miR-143-3p boosts extracellular vesicles to improve the dermal fibrosis of localized scleroderma.

A clinical guide to oral manifestations and diagnosis of limited systemic sclerosis: a case report.

Rasmussen encephalitis and localized scleroderma of the lower limb: Another piece of the puzzle. A case-report and literature review with individual participant data.

Incidence, prevalence, and mortality of localized scleroderma in Quebec, Canada: a population-based study.

Unique and shared transcriptomic signatures underlying localized scleroderma pathogenesis identified using interpretable machine learning.

The burden of extracutaneous manifestations in juvenile localized scleroderma: A literature review.

Solitary Morphea Profunda: A Case Report.

EFFICACY AND TOLERABILITY OF JANUS KINASE INHIBITOR TOFACITINIB IN JUVENILE LINEAR SCLERODERMA. CASE SERIES OF 5 PATIENTS.

Localized scleroderma: anatomic MRI findings of morphea with inter-reader analysis.

Socioeconomic factors associated with the development of localized scleroderma: a cross-sectional study.

Development of Coup de Sabre in an HIV-Positive Patient: A Case Study from Lilongwe, Malawi.

Nationwide epidemiological and clinical survey of juvenile-onset morphea in Japan.

[Oral localized scleroderma: case study].

Efficacy and safety of platelet-rich plasma therapy in systemic sclerosis and localized scleroderma; a systematic review.

Coexistence of Lichen Sclerosus and Morphea in a Single Vulvar Lesion.

Markers of Type 2 Inflammation and Immunosenescence Are Upregulated in Localized Scleroderma.

Use of biologic drug in the treatment of localized scleroderma and systemic sclerosis in children: A scoping review.

A Challenging Case of Eosinophilic Fasciitis Without Classic Histopathological Findings.

A case of localized scleroderma with variable response to excimer light therapy.

Comparative study between fractional CO2 laser (10,600 nm) and microneedling in treatment of morphea: dermoscopic and histopathological evaluation.

A case series of dermatopathological features in different types of morphea and their clinical correlates.

High-Density Fat Combined With Stromal Vascular Fraction Gel for the Treatment of Facial Localized Scleroderma.

Advanced Neuroimaging and Clinical Findings in a Case of Linear Scleroderma En Coup De Sabre Presenting With Seizures.

Imiquimod for the treatment of morphea: a systematic review.

What Is New in Morphea-Narrative Review on Molecular Aspects and New Targeted Therapies.

Benefits of the Topical JAK Inhibitor Delgocitinib in a Patient With Pediatric Localized Scleroderma.

Linear Scleroderma En Coup de Sabre: A Case Series With Eyelid Involvement and Management.

Profiling of Toll-like Receptors and Related Signaling Mediators in the Pathogenesis of Morphea.

Evaluation of Thiol Disulfide, Ischemia Modified Albumin, and Prolidase Parameters in Patients with Localized Scleroderma.

Association of Black Race with Demographic, Comorbidities, and Outcome Variables in Localized Scleroderma Patients: A Retrospective Analysis of the 2017 US National Inpatient Sample.

JOINT LESIONS - COMMON EXTRACUTANEOUS MANIFESTATION IN JUVENILE LOCALIZED SCLERODERMA.

STROKE AS A LIFE-THREATENING COMPLICATION IN CHILDREN WITH LINEAR SCLERODERMA OF FACE.

Evaluation of autologous fat grafting in the treatment of juvenile localized scleroderma with facial involvement.

National Registry for Childhood Onset Scleroderma I: Insights from the first 341 juvenile localized scleroderma patients.

Disabling pansclerotic morphoea: a century of discovery.

Heart transplantation in juvenile-onset systemic sclerosis with primary cardiac involvement: report of two cases and comprehensive literature review.

Retrospective Review of Morphea in Paediatric Patients with Skin of Colour.

Outcomes of Fat Grafting in the Active Versus Quiescent Phase of Localized Scleroderma.

Calcium Hydroxyapatite as a Co-adjuvant Treatment Option in a Patient With Morphea: A Report of a Case With a One-Year Follow-Up.

Characterization of Endothelial Cell Subclusters in Localized Scleroderma Skin with Single-Cell RNA Sequencing Identifies NOTCH Signaling Pathway.

Rare Case of Limited Systemic Sclerosis with Left Ventricle Aneurysm.

Comparative Study of Adipose-Derived Stem Cells from Localized Scleroderma Patients and Healthy Donors in Treating Skin Fibrosis.

Interferon-Gamma-Inducible Protein-10 (IP-10) and Tumor Necrosis Factor-α (TNF-α) as Serological Predictors of Active Disease Status in Localized Scleroderma.

Challenges and complications in juvenile localized scleroderma: A practical approach.

Histopathologic spectrum of morphea: a single-center retrospective study.

The causal effects of inflammatory and autoimmune skin diseases on thyroid diseases: evidence from Mendelian randomization study.

Spatial Transcriptomics Identifies Cellular and Molecular Characteristics of Scleroderma Skin Lesions: Pilot Study in Juvenile Scleroderma.

Exploring the relationship between morphea and malignancy: a decade-long single-center study of 204 patients.

Case Report: Exacerbation after fat grafting in patients with active localized scleroderma.

Single-cell RNA sequencing identifies inherent abnormalities of adipose-derived stem cells from nonlesional sites of patients with localized scleroderma.

Advances in the Management of Localized Scleroderma: A Systematic Review of Laser Therapy and Injectable Filler Approaches.

Magnetic Resonance Imaging in the Assessment and Management of Post-injection-Site Morphea.

[Bullous morphea: A rare form of localized scleroderma].

Endpoints and outcomes for localized scleroderma/morphea: a scoping literature review.

A Rare Case of Bullous Morphea Associated with Autoimmune Hepatitis.

The role of excimer light in dermatology: a review.

Scleroderma-like Lesions in a Patient Undergoing Combined Pembrolizumab and Routine Chemotherapy: A Case Report and Literature Review.

Capillaroscopy in the daily clinic of the pediatric rheumatologist.

Atypical chemokine receptor 1-positive endothelial cells mediate leucocyte infiltration and synergize with secreted frizzled-related protein 2/asporin-positive fibroblasts to promote skin fibrosis in systemic sclerosis.

A consensus-based electronic medical record template for pediatric morphea patient visits.

Extragenital lichen sclerosus et atrophicus-morphea overlap as an initial presentation of genital lichen sclerosus.

High-frequency ultrasound evaluation of morphea: Retrospective analytical study.

The Serological Evidence of Positive Rheumatoid Factor in Morphea Patients and Its Relation to Disease Severity.

Clinical and ultrasonographic evaluation of efficacy and safety of intralesional injection of autologous platelet-rich plasma in morphea: A comparative case series.

Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?

Localized Scleroderma Burden: A Scoping Review Focusing on the Health-Related Quality of Life, Mental Health, and Productivity.

Responsiveness to Change of the Morphea Activity Measure in Pediatric Patients.

Ultrasonographic Evaluation of Juvenile Localized Scleroderma: Enhancing Objectivity in Diagnosis and Management.

Evidence for the causal relationship between rheumatoid arthritis and localized scleroderma: a two-sample mendelian randomization study.

Overlap of Scleroderma and Class V Lupus Nephritis: A Rare Autoimmune Confluence.

Tracking Fat Grafts by Magnetic Resonance Imaging: A Comparative Study of Adolescent and Adult Patients with Stable Localized Scleroderma.

Intraoral Involvement in Linear Scleroderma En Coup De Sabre: A Case Report.

Interferons dominate damage and activity in juvenile scleroderma.

Automated anatomical landmark detection on 3D facial images using U-NET-based deep learning algorithm.

Transition to Adult Rheumatology Care: A Disease-Specific Guide.

Pre-scleroderma and new opportunities for preventive medicine.

Antibody status against measles and rubella in juvenile localized scleroderma patients on synthetic DMARDs: a prospective case-control study.

Consensus statement on the diagnosis and treatment of sclerosing diseases of the skin, Part 1: Localized scleroderma, systemic sclerosis and overlap syndromes.

Raynaud's phenomenon associated with psoriatic arthritis.

S2k guideline: Diagnosis and therapy of localized scleroderma.

Damage evaluation of craniofacial localized scleroderma using magnetic resonance imaging.

Juvenile eosinophilic fasciitis: a single center case series.

Nintedanib in systemic sclerosis treatment: a case report.

A Comparison of Clinical, Demographic and Treatment Characteristics of Pediatric-Onset and Adult-Onset Patients Diagnosed With Localized Scleroderma.

Mass spectrometry -based proteomic analysis of the skin of patients with localized scleroderma.

Clinical, Histologic, and Transcriptomic Evaluation of Sequential Fat Grafting for Morphea: A Nonrandomized Controlled Trial.

Novel multispectral imaging to predict disease progression in pediatric morphea.

Perspective to precision medicine in scleroderma.

The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution.

MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study.

Development of Morphea Following Treatment with an ADA Biosimilar: A Case Report.

[Juvenile localized scleroderma].

Measurement equivalence of the English and French versions of the self-efficacy to manage chronic disease scale: a Scleroderma Patient-Centered Intervention Network (SPIN) study.

Invited Response on: "Fat Grafting Reduces Skin Hyperpigmentation of Localized Scleroderma Patients: A Prospective Self-controlled Study".

Morphea Involving the Lips and Gingiva: A Rare Case Report.

Best clinical practice in the treatment of juvenile systemic sclerosis: expert panel guidance - the result of the International Hamburg Consensus Meeting December 2022.

Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity Scale.

Synthetic Nucleic Acid Antigens in Localized Scleroderma.

Clinical characteristics of juvenile systemic sclerosis in Korea: 31-year single-center study.

Letter on Fat Grafting Reduces Skin Hyperpigmentation of Localized Scleroderma Patients: A Prospective Self-controlled Study.

Brown adipose tissue transplantation improves skin fibrosis in localized scleroderma.

Patients with autoimmune skin diseases are at increased risk of adverse pregnancy outcomes.

Connective tissue nevus misdiagnosed as juvenile localized scleroderma.

BULGARIAN PATIENT WITH ATROPHODERMA OF PASINI AND PIERINI- DESCRIPTION OF A CASE AND SHORT UPDATE.

Nodular (keloidal) scleroderma.

Orthodontic management of a patient with linear morphea.

Morphea, Eosinophilic Fasciitis and Cancer: A Scoping Review.

Systematic Review of Health-Related Quality of Life Impact in Juvenile Localized Scleroderma.

Exosomes from human adipose-derived mesenchymal stem cells attenuate localized scleroderma fibrosis by the let-7a-5p/TGF-βR1/Smad axis.

Clinical and Histological Characteristics of Localized Morphea, Generalized Morphea and Systemic Sclerosis: A Comparative Study Aided by Machine Learning.

A case of transient paradoxical early morphea-like eruption after the first injection of dupilumab in a patient with chronic rhinosinusitis with nasal polyps.

Arsenic trioxide demonstrates efficacy in a mouse model of preclinical systemic sclerosis.

Bony Hyperplasia Beneath Atrophic Soft Tissue: A Rare Case of En Coup de Sabre and Literature Review.

IL-6 trans-signaling in a humanized mouse model of scleroderma.

Does the Impact of COVID-19 on Patients With Systemic Sclerosis Change Over Time?

Diagnosing and Managing Linear Scleroderma in a Low-Resource Setting.

Images in Vascular Medicine: Subcutaneous panniculitis-like T-cell lymphoma mimicking lipodermatosclerosis.

Fat Grafting Reduces Skin Hyperpigmentation of Localized Scleroderma Patients: A Prospective Self-controlled Study.

The Reactivation of Scleroderma After Autologous Fat Grafting.

Free Superficial Circumflex Iliac Artery/Superficial Inferior Epigastric Artery Adipofascial Flaps for Facial Reconstruction of Linear Scleroderma.

En Coup de Sabre in a Pediatric Patient Treated With Calcipotriene.

Color Doppler Ultrasound Assessment of Subclinical Activity With Scoring of Morphea.

Non-invasive imaging and clinical skin scores in juvenile localized scleroderma.

Role of imaging in morphea assessment: A review of the literature.

The Collaborative National Quality and Efficacy Registry for Scleroderma: association of medication use on gastrointestinal tract symptoms in early disease and the importance of tobacco cessation.

Pansclerotic morphea is characterized by IFN-γ responses priming dendritic cell fibroblast crosstalk to promote fibrosis.

Systemic therapy in juvenile localized scleroderma.

Case Report: Real NPSLE? A patient with systemic sclerosis overlapping systemic lupus erythematosus presenting as epilepsy.

Spontaneous crateriform indentation in a child.

Transplantation of in vitro prefabricated adipose organoids attenuates skin fibrosis by restoring subcutaneous fat and inducing dermal adipogenesis.

Learnings from clinical trials in patients with connective tissue disease-associated interstitial lung disease.